These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 39129491
1. 5-Aminoimidazole-4-carboxamide ribonucleotide formyltransferase/inosine monophosphate cyclohydrolase promotes pulmonary arterial smooth muscle cell proliferation via the Ras signaling pathway. Shi X, Ma Q, Huo Y, Su Y. Am J Physiol Cell Physiol; 2024 Oct 01; 327(4):C901-C912. PubMed ID: 39129491 [Abstract] [Full Text] [Related]
2. Purine synthesis suppression reduces the development and progression of pulmonary hypertension in rodent models. Ma Q, Yang Q, Xu J, Sellers HG, Brown ZL, Liu Z, Bordan Z, Shi X, Zhao D, Cai Y, Pareek V, Zhang C, Wu G, Dong Z, Verin AD, Gan L, Du Q, Benkovic SJ, Xu S, Asara JM, Ben-Sahra I, Barman S, Su Y, Fulton DJR, Huo Y. Eur Heart J; 2023 Apr 07; 44(14):1265-1279. PubMed ID: 36721994 [Abstract] [Full Text] [Related]
3. Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension. Yamamura A, Fujiwara M, Kawade A, Amano T, Hossain A, Nayeem MJ, Kondo R, Suzuki Y, Inoue Y, Hayashi H, Suzuki S, Sato M, Yamamura H. Eur J Pharmacol; 2024 Jun 15; 973():176564. PubMed ID: 38614383 [Abstract] [Full Text] [Related]
9. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal. Yang Y, Yin L, Zhu M, Song S, Sun C, Han X, Xu Y, Zhao Y, Qi Y, Xu L, Peng JY. Biomed Pharmacother; 2021 Jan 01; 133():111056. PubMed ID: 33378960 [Abstract] [Full Text] [Related]
10. Activation of Calpain-2 by Mediators in Pulmonary Vascular Remodeling of Pulmonary Arterial Hypertension. Kovacs L, Han W, Rafikov R, Bagi Z, Offermanns S, Saido TC, Black SM, Su Y. Am J Respir Cell Mol Biol; 2016 Mar 01; 54(3):384-93. PubMed ID: 26248159 [Abstract] [Full Text] [Related]
13. Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension. Chen X, Yu X, Lian G, Tang H, Yan Y, Gao G, Huang B, Luo L, Xie L. Biomed Pharmacother; 2024 May 01; 174():116505. PubMed ID: 38574614 [Abstract] [Full Text] [Related]
14. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology. Meloche J, Courchesne A, Barrier M, Carter S, Bisserier M, Paulin R, Lauzon-Joset JF, Breuils-Bonnet S, Tremblay É, Biardel S, Racine C, Courture C, Bonnet P, Majka SM, Deshaies Y, Picard F, Provencher S, Bonnet S. J Am Heart Assoc; 2013 Jan 16; 2(1):e005157. PubMed ID: 23525442 [Abstract] [Full Text] [Related]
15. Notch3 signaling activation in smooth muscle cells promotes extrauterine growth restriction-induced pulmonary hypertension. Wang Y, Dai S, Cheng X, Prado E, Yan L, Hu J, He Q, Lv Y, Lv Y, Du L. Nutr Metab Cardiovasc Dis; 2019 Jun 16; 29(6):639-651. PubMed ID: 30954415 [Abstract] [Full Text] [Related]